Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

132 results about "Phospholipases C" patented technology

Potentially fluorogenic compounds and plating media containing same

Compounds of formula (I)in which R1, R2, R3, R4 and R5 are hydrogen atoms or chromogenic substituents and X is hydroxyl, OR6 wherein R6 is selected from the group consisting of C1-C4 alkyl, or O-Me+ wherein Me+ is a cation derived from an organic or inorganic base; these compounds do not exhibit significant fluorescence but are capable of being cleaved by phosphatidyl-inositol-specific phospholipase C, an enzyme which is indicative of bacterial activity; the umbelliferyl moity resulting from such cleavage is a strong fluorogen thus providing effective test methods for various pathogenic bacteria, such as Listeria, Staphylococcus and Clostridium species. Also disclosed are plating media for detection of microorganisms that are capable of metabolic generation of a phosphatidyl inositol-specific phospholipase C (PI-PLC). The plating medium can be in a dry, liquid, or semi-liquid form, depending upon its water content, and comprise at least one compound capable of forming an aqueous gel when in contact with water; at least one nutrient capable of supporting growth of said microorganism; and at least one indicator compound of formula I and / or IV, notably 4-methylumbelliferyl myo-inositol-1-phosphate or salts thereof and 5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate or salts thereof. PI-PLC generated by the microorganisms of interest leads to cleavage of the indicator compounds causing formation of fluorescence and / or color suitable for identification of type and count of such hygienically and pathologically important microorganisms as Listeria species.
Owner:BIOSYNTH

Recombinant escherichia coli, method for preparing phospholipase C and method for degumming soybean crude oil

The invention discloses recombinant escherichia coli, a method for preparing phospholipase C and a method for degumming soybean crude oil. The method for preparing phospholipase C (PLC) is finished by the following steps: (1) cloning by taking genome deoxyribonucleic acid (DNA) of staphylococcus aureus of which the preservation number is GIM1.142 (ATCC6538) as a template to obtain a phospholipase C gene, wherein a base sequence of phospholipase C gene is shown in SEQ ID NO:1 (2) cloning the phospholipase C gene obtained in the step (1) to a pET-28a(+) expression carrier, and building recombinant expression plasmids; (3) transforming the recombinant expression plasmids obtained in the step (2) into escherichia coli BL21(DE3) competent cells, so as to obtain the recombinant escherichia coli BL21(28a-S.a PLC). In the method for degumming soybean crude oil, phospholipase C produced by the recombinant escherichia coli is taken as a catalyst, so that the enzyme source is convenient, the yield is high, the fermentation technology is simple, and the cost is low. Compared with the traditional enzyme degumming, the method for degumming soybean crude oil by adopting phospholipase C has the advantages that the reaction time can be shortened; loss of neutral oil is reduced; the refining yield is improved. Therefore, the degumming method disclosed by invention has a certain application prospect in the field of the oil production industry.
Owner:JIANGNAN UNIV

Novel potentially fluorogenic compounds and plating media containing same

Compounds of formula (I) in which R1,R2,R3,R4 and R5 are hydrogen atoms or chromogenic substituents and X is hydroxyl, OR6 wherein R6 is selected from the group consisting of C1-C4 alkyl, or O-Me+ wherein Me+ is a cation derived from an organic or inorganic base; these compounds do not exhibit significant fluorescence but are capable of being cleaved by phosphatidyl-inositol-specific phospholipase C, an enzyme which is indicative of bacterial activity; the umbelliferyl moity resulting from such cleavage is a strong fluorogen thus providing effective test methods for various pathogenic bacteria, such as Listeria, Staphylococcus and Clostridium species. Also disclosed are plating media for detection of microorganisms that are capable of metabolic generation of a phosphatidyl inositol-specific phospholipase C (PI-PLC). The plating medium can be in a dry, liquid, or semi-liquid form, depending upon its water content, and comprise at least one compound capable of forming an aqueous gel when in contact with water; at least one nutrient capable of supporting growth of said microorganism; and at least one indicator compound of formula I and/or IV, notably 4-methylumbelliferyl myo-inositol-1-phosphate or salts thereof and 5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate or salts thereof. PI-PLC generated by the microorganisms of interest leads to cleavage of the indicator compounds causing formation of fluorescence and/or color suitable for identification of type and count of such hygienically and pathologically important microorganisms as Listeria species.
Owner:BIOSYNTH

Mutton fat degumming method

ActiveCN105623847AEffectively catalyzes non-hydratable phospholipidsAvoid it happening againFatty-oils/fats refiningBiotechnologyAnimal science
The invention discloses a mutton fat degumming method which comprises the following steps that a citric acid solution is added to a mutton fat raw material, acidizing is conducted under assistance of ultrasonic waves, and acidized mutton fat is obtained; a certain quantity of distilled water is added to the acidized mutton fat, the pH and the temperature of the acidized mutton fat are adjusted, phospholipase A1 is added for conducting ultrasound-assisted enzymolysis, and the mutton fat obtained after preliminary enzymolysis is obtained; the pH and the temperature of the mutton fat obtained after preliminary enzymolysis are adjusted, phospholipase B is added for conducting ultrasound-assisted enzymolysis, and mutton fat obtained after secondary enzymolysis is obtained; the pH and the temperature of the mutton fat obtained after secondary enzymolysis are adjusted, phospholipase C is added for conducting ultrasound-assisted enzymolysis, and mutton fat obtained after third enzymolysis is obtained, enzyme deactivation processing is conducted on the mutton fat obtained after third enzymolysis, centrifugation is conducted to take fat samples on the upper layer, and mutton fat obtained after enzyme deactivation is conducted is obtained; the mutton fat obtained after enzyme deactivation is conducted is subjected to vacuum drying processing, and degummed mutton fat is obtained. The mutton fat degumming method is safe in process and convenient and fast to operate.
Owner:WUHAN POLYTECHNIC UNIVERSITY

150 KDA TGF-B1 accessory receptor acts a negative modulator of TGF-B signaling

The present invention relates to a TGF-β1 binding protein called r150. This protein has a GPI-anchor contained in r150 itself and not on a tightly associated protein and that it binds TGF-β1 with an affinity comparable to those of the signaling receptors. Furthermore, the released (soluble) form of this protein binds TGF-β1 independent of the types I and II receptors. Also, the soluble form inhibits the binding of TGF-β to its receptor. In addition, evidence that r150 is released from the cell surface by an endogenous phospholipase C is provided. Also, the creation of a mutant human keratinocyte cell line with a defect in GPI synthesis which displays reduced expression of r150 is described. Our results using these mutant keratinocytes suggest that the membrane anchored form of r150 is a negative modulator of TGF-beta responses. These findings, taken together with the observation that r150 forms a heteromeric complex with the signaling receptors, suggest that this accessory receptor in either its membrane anchored or soluble form may antagonize TGF-β responses in human keratinocytes. Experiments with mutants confirmed that TGFβ1 activity can be modulated when the expression of the accessory receptor r150 is silenced. The complete nucleic acid and deduced amino acid sequences are now provided. The r150 cloned nucleic acid was used to study overexpression of r150. When r150 gene is overexpressed, TGFβ responses are increased. r150 and its derivatives or precursors (fragments, variants and nucleic acids encoding the same) will find a broad clinical utility, knowing that TGFβ1 is an important cytokine.
Owner:9406 2668 QUEBEC INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products